Clinical Challenges: Myeloma and Concomitant Type 2 Diabetes

Multiple myeloma is a malignant plasma cell disorder that accounts for approximately 10% of all hematologic cancers. It is characterized by accumulation of clonal plasma cells, predominantly in the bone marrow. The prevalence of type 2 diabetes is increasing; therefore, it is expected that there wil...

Descripción completa

Detalles Bibliográficos
Autores principales: Ahmed, Yasar Albushra Abdul Rahiem, Eltayeb, Awad
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Tehran University of Medical Sciences 2013
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3913129/
https://www.ncbi.nlm.nih.gov/pubmed/24505516
_version_ 1782302181647450112
author Ahmed, Yasar Albushra Abdul Rahiem
Eltayeb, Awad
author_facet Ahmed, Yasar Albushra Abdul Rahiem
Eltayeb, Awad
author_sort Ahmed, Yasar Albushra Abdul Rahiem
collection PubMed
description Multiple myeloma is a malignant plasma cell disorder that accounts for approximately 10% of all hematologic cancers. It is characterized by accumulation of clonal plasma cells, predominantly in the bone marrow. The prevalence of type 2 diabetes is increasing; therefore, it is expected that there will be an increase in the diagnosis of multiple myeloma with concomitant diabetes mellitus. The treatment of multiple myeloma and diabetes mellitus is multifaceted. The coexistence of the two conditions in a patient forms a major challenge for physicians
format Online
Article
Text
id pubmed-3913129
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher Tehran University of Medical Sciences
record_format MEDLINE/PubMed
spelling pubmed-39131292014-02-06 Clinical Challenges: Myeloma and Concomitant Type 2 Diabetes Ahmed, Yasar Albushra Abdul Rahiem Eltayeb, Awad Int J Hematol Oncol Stem Cell Res Review Article Multiple myeloma is a malignant plasma cell disorder that accounts for approximately 10% of all hematologic cancers. It is characterized by accumulation of clonal plasma cells, predominantly in the bone marrow. The prevalence of type 2 diabetes is increasing; therefore, it is expected that there will be an increase in the diagnosis of multiple myeloma with concomitant diabetes mellitus. The treatment of multiple myeloma and diabetes mellitus is multifaceted. The coexistence of the two conditions in a patient forms a major challenge for physicians Tehran University of Medical Sciences 2013 /pmc/articles/PMC3913129/ /pubmed/24505516 Text en © 2013 Hematology-Oncology and Stem Cell Transplantation Research Center, Tehran University of Medical Sciences http://creativecommons.org/licenses/by-nc/3.0/ This work is licensed under a Creative Commons Attribution-NonCommercial 3.0 Unported License which allows users to read, copy, distribute and make derivative works for non-commercial purposes from the material, as long as the author of the original work is cited properly.
spellingShingle Review Article
Ahmed, Yasar Albushra Abdul Rahiem
Eltayeb, Awad
Clinical Challenges: Myeloma and Concomitant Type 2 Diabetes
title Clinical Challenges: Myeloma and Concomitant Type 2 Diabetes
title_full Clinical Challenges: Myeloma and Concomitant Type 2 Diabetes
title_fullStr Clinical Challenges: Myeloma and Concomitant Type 2 Diabetes
title_full_unstemmed Clinical Challenges: Myeloma and Concomitant Type 2 Diabetes
title_short Clinical Challenges: Myeloma and Concomitant Type 2 Diabetes
title_sort clinical challenges: myeloma and concomitant type 2 diabetes
topic Review Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3913129/
https://www.ncbi.nlm.nih.gov/pubmed/24505516
work_keys_str_mv AT ahmedyasaralbushraabdulrahiem clinicalchallengesmyelomaandconcomitanttype2diabetes
AT eltayebawad clinicalchallengesmyelomaandconcomitanttype2diabetes

Ejemplares similares